Costa D, Nobre J, de Almeida S, Ferreira M, Goncalves I, Braga S
Front Oncol. 2021; 10:598508.
PMID: 33425755
PMC: 7787159.
DOI: 10.3389/fonc.2020.598508.
Khoury T, Gaudioso C, Fang Y, Sanati S, Opyrchal M, Desouki M
Breast J. 2017; 24(1):41-50.
PMID: 28597587
PMC: 5722717.
DOI: 10.1111/tbj.12830.
Silverman D, Ruth K, Sigurdson E, Egleston B, Goldstein L, Wong Y
J Am Coll Surg. 2014; 219(3):534-44.
PMID: 25026875
PMC: 4143438.
DOI: 10.1016/j.jamcollsurg.2014.04.003.
Eikesdal H, Knappskog S, Aas T, Lonning P
Acta Oncol. 2014; 53(10):1347-55.
PMID: 24909504
PMC: 4245178.
DOI: 10.3109/0284186X.2014.922215.
Beriwal S, Rungruang B, Soran A, Thull D, Kelley J, Bhargava R
Cancers (Basel). 2013; 1(1):12-20.
PMID: 24280969
PMC: 3757348.
DOI: 10.3390/cancers1010012.
Primary Endocrine Therapy for Locally Advanced Breast Cancer-Is it an Inferior Approach? Experience from Nottingham.
Lakshmanan R, Cheung K
Indian J Surg Oncol. 2012; 1(3):224-7.
PMID: 22693369
PMC: 3244247.
DOI: 10.1007/s13193-010-0035-5.
The Changing Face of Mastectomy (from Mutilation to Aid to Breast Reconstruction).
Zurrida S, Bassi F, Arnone P, Martella S, Del Castillo A, Ribeiro Martini R
Int J Surg Oncol. 2012; 2011:980158.
PMID: 22312537
PMC: 3263661.
DOI: 10.1155/2011/980158.
Combined low initial DNA damage and high radiation-induced apoptosis confers clinical resistance to long-term toxicity in breast cancer patients treated with high-dose radiotherapy.
Henriquez-Hernandez L, Carmona-Vigo R, Pinar B, Bordon E, Lloret M, Isabel Nunez M
Radiat Oncol. 2011; 6:60.
PMID: 21645372
PMC: 3117708.
DOI: 10.1186/1748-717X-6-60.
Hyperthermia for locally advanced breast cancer.
Zagar T, Oleson J, Vujaskovic Z, Dewhirst M, Craciunescu O, Blackwell K
Int J Hyperthermia. 2010; 26(7):618-24.
PMID: 20849257
PMC: 2949291.
DOI: 10.3109/02656736.2010.501051.
The role of 18F-FDG PET/CT in evaluation of early response to neoadjuvant chemotherapy in patients with locally advanced breast cancer.
Kumar A, Kumar R, Seenu V, Gupta S, Chawla M, Malhotra A
Eur Radiol. 2009; 19(6):1347-57.
PMID: 19214522
DOI: 10.1007/s00330-009-1303-z.
Discussion; the treatment of cancer of the breast.
Gordon-Taylor G, McWhirter R
Proc R Soc Med. 1948; 41(2):118-32.
PMID: 18903033
PMC: 2184476.
General surgical complications of pregnancy.
McCARTY R
Calif Med. 1948; 69(6):440-4.
PMID: 18099072
PMC: 1643631.
Pathological complete response and residual DCIS following neoadjuvant chemotherapy for breast carcinoma.
Jones R, Lakhani S, Ring A, Ashley S, Walsh G, Smith I
Br J Cancer. 2006; 94(3):358-62.
PMID: 16421590
PMC: 2361141.
DOI: 10.1038/sj.bjc.6602950.
Oestrogen receptor status, pathological complete response and prognosis in patients receiving neoadjuvant chemotherapy for early breast cancer.
Ring A, Smith I, Ashley S, Fulford L, Lakhani S
Br J Cancer. 2004; 91(12):2012-7.
PMID: 15558072
PMC: 2409783.
DOI: 10.1038/sj.bjc.6602235.
Phase II study of neoadjuvant paclitaxel and cisplatin for operable and locally advanced breast cancer: analysis of 126 patients.
Ezzat A, Ibrahim E, Ajarim D, Rahal M, Raja M, Tulbah A
Br J Cancer. 2004; 90(5):968-74.
PMID: 14997191
PMC: 2409621.
DOI: 10.1038/sj.bjc.6601616.
Survival after surgical treatment of breast cancer.
Taucher S, Jakesz R
Langenbecks Arch Surg. 2004; 389(2):75-82.
PMID: 14985988
DOI: 10.1007/s00423-004-0465-z.
Further studies on prognosis of breast carcinoma.
BLOOM H
Br J Cancer. 1950; 4(4):347-67.
PMID: 14801342
PMC: 2007734.
DOI: 10.1038/bjc.1950.34.
Prognosis in carcinoma of the breast.
BLOOM H
Br J Cancer. 1950; 4(3):259-88.
PMID: 14783659
PMC: 2007665.
DOI: 10.1038/bjc.1950.26.
Management of patients with locally advanced breast cancer.
Newman L
Curr Oncol Rep. 2003; 6(1):53-61.
PMID: 14664762
DOI: 10.1007/s11912-996-0010-z.
Deceptive association in clinical data.
Johnson R
Ann Surg. 1955; 141(4):567-71.
PMID: 14362393
PMC: 1609808.
DOI: 10.1097/00000658-195504000-00022.
